By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Robert W. Baird has upped its rating on Sigma-Aldrich's stock to "outperform" from "neutral," a day after the firm beat Wall Street expectations for fourth-quarter revenues and net income.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.